Canostix is a brand that is tirelessly working towards creating affordable cancer screening options for everyone. They are dedicated to developing a revolutionary method to diagnose cancer using photonics and big data. This innovative approach will allow for population-wide cancer screening, making it easier for patients and doctors to detect the disease early on for more effective treatment.

Canostix is made up of a small team of multidisciplinary scientists who are passionate about bringing cancer diagnostics into the 21st century. They combine well-planned and promising research within a highly creative start-up environment to achieve their vision. The team includes CEO Dr.

Thaddäus Hocotz, a medical doctor experienced in spectroscopic cancer diagnostics research, and data analyst Lukasz Pieszczek, who specializes in data science and spectroscopic chemical analysis. With Canostix, the future of cancer screening looks brighter and more accessible